Production of Extracellular Proteolytic Activity by Histoplasma Capsulatum Grown in Histoplasma-macrophage Medium is Limited to Restriction Fragment Length Polymorphism Class 1 Isolates
Overview
Microbiology
Pathology
Affiliations
Extracellular proteolytic activity was studied for 28 strains of Histoplasma capsulatum var. capsulatum and 2 strains of H. capsulatum var. duboisii. Secreted protease activity assessed by skim milk agarose clearance was limited solely to H. capsulatum var. capsulatum restriction fragment length polymorphism (RFLP) class 1 strains. There was a difference in proteolytic activity levels among class 1 strains. Extracellular proteolytic activity was further determined during growth of those strains in liquid medium using azodye-impregnated protein substrates. In general, the highest activities were measured when azocollagen was used, whereas azocasein and azoalbumin were cleaved less efficiently. The activity was inhibited by phenylmethylsulfonyl fluoride, 4-(2-aminoethyl) benzenesulfonyl fluoride, antipain, and chymostatin, indicating, thereby, the presence of chymotrypsin-like serine proteases. Chromatographic analyses as well as variable substrate use at different culture times revealed production of at least 2 different enzyme pools of the same serine-like protease family. Our results demonstrate a distinctive ability of RFLP class 1 isolates to produce and secrete serine proteinase-type activity. This peculiarity may be relevant to the biology and pathogenesis of this particular clade of H. capsulatum isolates. Overall, the feature of extracellular proteolytic activity production enables a convenient and unequivocal identification of RFLP class 1 isolates and, thereby, can be used in H. capsulatum strain differentiation and typing.
Three transporters, including the novel Gai1 permease, drive amino acid uptake in yeasts.
Ray S, Shen Q, Rappleye C Virulence. 2024; 15(1):2438750.
PMID: 39652632 PMC: 11633205. DOI: 10.1080/21505594.2024.2438750.
Phenotypic characterization of cryptic species in the fungal pathogen .
Sepulveda V, Rader J, Li J, Goldman W, Matute D mSphere. 2024; 9(6):e0000924.
PMID: 38771035 PMC: 11332167. DOI: 10.1128/msphere.00009-24.
Nanjaiah M, Rastogi N, Devappa S 3 Biotech. 2024; 14(2):49.
PMID: 38268985 PMC: 10803690. DOI: 10.1007/s13205-023-03899-z.
Phenotypic characterization of cryptic species in the fungal pathogen .
Sepulveda V, Rader J, Li J, Goldman W, Matute D bioRxiv. 2024; .
PMID: 38260643 PMC: 10802462. DOI: 10.1101/2024.01.08.574719.
Shen Q, Ray S, Evans H, Deepe Jr G, Rappleye C mBio. 2020; 11(2).
PMID: 32265333 PMC: 7157778. DOI: 10.1128/mBio.02712-19.